Bruker (BRKR) Invested Capital (2010 - 2026)

Bruker (BRKR) has reported Invested Capital for 17 consecutive years, with $4.2 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Invested Capital fell 0.7% year-over-year to $4.2 billion; the trailing twelve-month figure through Jun 2026 stood at $4.2 billion (down 0.7% YoY), and the FY2025 full-year result was $4.4 billion, up 12.57% from the prior year.
• Invested Capital advanced to $4.2 billion in Q2 2026 per BRKR's latest filing, from $4.1 billion in the prior quarter.
• Across five years, Invested Capital topped out at $4.5 billion in Q3 2025 and bottomed at $2.1 billion in Q3 2022.
• Historically, Invested Capital has averaged $3.3 billion across 5 years, with a median of $3.4 billion in 2024.
• The sharpest annual moves came in 2022 and 2024: Invested Capital declined 3.27% in 2022, then soared 68.49% in 2024.
• Over 5 years, Invested Capital stood at $2.3 billion in 2022, then increased by 14.12% to $2.7 billion in 2023, then surged by 45.4% to $3.9 billion in 2024, then advanced by 12.57% to $4.4 billion in 2025, then declined by 3.58% to $4.2 billion in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $4.2 billion, $4.1 billion, and $4.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.